| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 62 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 61 |
| 2 | TACROLIMUS OINTMENT 0.1% | 61 |
| 3 | MYCOPHENOLATE MOFETIL | 43 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 43 |
| 5 | PREDNISONE | 30 |
| 6 | MYCOPHENILIC ACID | 17 |
| 7 | MYCOPHENOLIC ACID | 17 |
| 8 | PAZOPANIB HYDROCHLORIDE | 17 |
| 9 | METHYLPREDNISOLONE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 9 | 0.0011 |
| 2 | TRABECTEDIN | 2 | 0.0009 |
| 3 | MYCOPHENILIC ACID | 17 | 0.0008 |
| 4 | PAZOPANIB HYDROCHLORIDE | 17 | 0.0006 |
| 5 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 6 | MYCOPHENOLIC ACID | 17 | 0.0005 |
| 7 | TACROLIMUS OINTMENT 0.1% | 61 | 0.0005 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 61 | 0.0005 |
| 9 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 17 | 0.0008 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 2 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Microtubule Inhibitor [EPC] | 13 | 0.0001 |
| 6 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Corticosteroid [EPC] | 50 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 9 | 0.0000 |